VIMTA LABS
Back to Income Statement
|
VIMTA LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹41 Cr | ₹48 Cr | ₹41 Cr | ₹21 Cr | ₹6.85 Cr |
What is the latest Consolidated Net Profit of VIMTA LABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹21 Cr |
| Mar2020 | ₹6.85 Cr |
How is Consolidated Net Profit of VIMTA LABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹41 Cr | -14.87 | |
| Mar2023 | ₹48 Cr | 16.55 | |
| Mar2022 | ₹41 Cr | 93.09 | |
| Mar2021 | ₹21 Cr | 212.71 | |
| Mar2020 | ₹6.85 Cr | - | |
Compare Consolidated Net Profit of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,938.3 Cr | -5% | -27.5% | 10.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -5% |
-27.5% |
10.5% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses